Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 2, 2012, Pages 306-314

  Esposito, Elisabetta ^a   Mariani, Paolo ^b   Ravani, Laura ^a   Contado, Catia ^a   Volta, Mattia ^a   Bido, Simone ^a   Drechsler, Markus ^c   Mazzoni, Serena ^b   Menegatti, Enea ^a   Morari, Michele ^a   Cortesi, Rita ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Bar test; Bromocriptine (BC); Drag test; Nanostructured Lipid Carrier (NLC); Solid Lipid Nanoparticles (SLNs); X ray

Indexed keywords

BROMOCRIPTINE; DRUG CARRIER; MONOOLEIN AQUEOUS DISPERSION; NANOSTRUCTURED LIPID CARRIER; OXIDOPAMINE; UNCLASSIFIED DRUG;

AKINESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; BRADYKINESIA; CONFERENCE PAPER; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; FIELD FLOW FRACTIONATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID DISPERSION; MALE; MOTOR DYSFUNCTION; NANOENCAPSULATION; NONHUMAN; PARKINSON DISEASE; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; RAT; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 84856604331     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.10.015     Document Type: Article

References (52)

1. A. Yaghmur, and O. Glatter Characterization and potential applications of nanostructured aqueous dispersions Adv. Coll. Interf. Sci. 148 2009 333 342
2. K. Westesen, and B. Siekmann Biodegradable colloidal drug carrier systems based on solid lipids S. Benita, Microencapsulation 1996 Marcel Dekker New York 213 258
3. R.H. Muller, K. Mader, and S. Gohla Solid lipid nanoparticles (SLN) for controlled delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177 (Pubitemid 30326695)
4. J. Pardeike, A. Hommoss, and R.H. Müller Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products Int. J. Pharm. 366 2009 170 184
5. R.H. Muller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Del. Rev. 54 2002 S131s S155
6. J. Gustafsson, H. Ljusberg-Wharen, M. Almgrem, and K. Larsson Cubic lipid/water phase dispersed into submicron particles Langmuir 12 1996 4611 4613
7. L. de campo, A. Yaghmur, L. Sagalowicz, M.E. Leser, H. Watzke, and O. Gattler Reversible phase transitions in emulsified nanostructured lipid systems Langmuir 20 2004 5254 5261
8. J. Gustafsson, H. Ljusberg-Wharen, M. Almgrem, and K. Larsson Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer Langmuir 13 1997 6964 6971 (Pubitemid 127601886)
9. E. Esposito, N. Eblovi, S. Rasi, M. Drechsler, G.M. Di Gregorio, E. Menegatti, and R. Cortesi Lipid based supramolecular systems for topical application: a preformulatory study AAPS Pharm. Sci. 5 2003 4 (article 30)
10. P.T. Spicer, and K.L. Hayden Novel process for producing cubic liquid crystalline nanoparticles (cubosomes) Langmuir 17 2001 5748 5756 (Pubitemid 35330732)
11. M. Nakano, A. Sugita, H. Matsuoka, and T. Handa Small angle X-ray scattering and 13C NMR investigation on the internal structure of cubosome Langmuir 17 2001 3917 3922 (Pubitemid 35330342)
12. L. Sagalowicz, R. Mezzenga, and M.E. Leser Investigating reversed liquid crystalline mesophases Curr. Opin. Colloid Interf. Sci. 11 2006 224 229 (Pubitemid 44755357)
13. J. Lai, J. Chen, Y. Lu, J. Sun, F. Hu, Z. Yin, and W. Wu Glyceryl monooleate/Poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin AAPS Pharm. Sci. Technol. 10 2009 960 966
14. E. Barbu, É. Molnàr, J. Tsibouklis, and D.C. Górecki The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier Expert Opin. Drug Del. 6 2009 553 565
15. S. Pasha, and K. Gupta Various drug delivery approaches to the central nervous system Expert Opin. Drug Del. 7 2010 113 135
16. V. Kabanov, and E.V. Batrakova New technologies for drug delivery across the blood brain barrier Curr. Pharm. Des. 10 2004 1355 1363 (Pubitemid 38578372)
17. K. Andrieux, and P. Couvreur Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier Nanomed. Nanobiotechnol. 1 2009 463 474
18. I.P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar Potential of solid lipid nanoparticles in brain targeting J. Control. Rel. 127 2008 97 109
19. M.D. Joshi, and R.H. Müller Lipid nanoparticles for parenteral delivery of actives Eur. J. Pharm. Biopharm. 71 2009 161 172
20. E. Esposito, M. Fantin, M. Marti, M. Drechsler, L. Paccamiccio, P. Mariani, E. Sivieri, F. Lain, E. Menegatti, M. Morari, and R. Cortesi Solid lipid nanoparticles as delivery systems for bromocriptine Pharm. Res. 25 2008 1521 1530
21. http://www.fscimage.fishersci.com/msds/06352.html.
22. E. Esposito, R. Cortesi, M. Drechsler, L. Paccamiccio, P. Mariani, C. Contado, E. Stellin, E. Menegatti, F. Bonina, and C. Puglia Cubosome dispersions as delivery systems for percutaneous administration of indomethacin Pharm. Res. 22 2005 2163 2173 (Pubitemid 41821596)
23. R. Pecora Dynamic light scattering measurement of nanometer particles in liquids J. Nanoparticle Res. 2 2000 123 131 (Pubitemid 33230006)
24. C. Contado, A. Dalpiaz, E. Leo, M. Zborowski, and P.S. Williams Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres J. Chromatogr. A 1157 2007 321 335 (Pubitemid 46963284)
25. C. Contado, G. Blo, F. Fagioli, F. Dondi, and R. Beckett Characterisation of River Po particles by sedimentation field-flow fractionation coupled to GFAAS and ICP-MS Colloid Surf. A - Physicochem. Eng. Asp. 120 1997 47 59 (Pubitemid 27128040)
26. P. Andreozzi, S.S. Funari, C. La Mesa, P. Mariani, M.G. Ortore, R. Sinibaldi, and F. Spinozzi Multi- to unilamellar transitions in catanionic vesicles J. Phys. Chem. B 114 2010 8056 8060
27. P. Mariani, V. Luzzati, and H. Delacroix Cubic phases of lipid containing systems. Structure analysis and biological implications J. Mol. Biol. 204 1988 165 189
28. F. Spinozzi, L. Paccamiccio, P. Mariani, and L.Q. Amaral Melting regime of the anionic phospholipid DMPG: new lamellar phase and porous bilayer model Langmuir 26 2010 6484 6493
29. M. Marti, F. Mela, M. Fantin, S. Zucchini, J. M Brown, J. Witta, M. Di Benedetto, B. Buzas, R.K. Reinscheid, S. Salvadori, R. Guerrini, P. Romualdi, S. Candeletti, M. Simonato, B.M. Cox, and M. Morari Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease J. Neurosci. 95 2005 9591 9601 (Pubitemid 41510900)
30. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1982 Academic Sydney
31. M. Marti, C. Trapella, R. Viaro, and M. Morari The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway J. Neurosci. 27 2007 1297 1307
32. M. Marti, F. Mela, C. Bianchi, L. Beani, and M. Morari Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo. Opposite role for D1 and D2 receptors J. Neurochem. 83 2002 635 644 (Pubitemid 35231817)
33. P.R. Sanberg, M.D. Bunsey, M. Giordano, and A.B. Norman The catalepsy test: its ups and downs Behav. Neurosci. 102 1988 748 759
34. T. Schallert, M. De Rick, I.Q. Whishaw, V.D. Ramirez, and P. Teitelbaum Excessive bracing reactions and their control by atropine and L-DOPA in an animal analog of Parkinsonism Exp. Neurol. 64 1979 33 43 (Pubitemid 9185685)
35. C. Nastruzzi, C. Pastesini, R. Cortesi, E. Esposito, R. Gambari, and E. Menegatti Kinetic of bromocriptine release from microspheres: comparative analysis between different in vitro models J. Microencapsul. 11 1993 565 574
36. E. Esposito, R. Cortesi, E. Menegatti, and C. Nastruzzi Preformed gelatin microspheres as a delivery system for bromocriptine Pharm. Sci. Comm. 4 1994 239 246
37. R. Mahajan Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes Indian J. Pharmacol. 41 2009 197 198
38. G. Garg, S. Saraf, and S. Saraf Cubosomes: an overview Biol. Pharm. Bull. 30 2007 350 353
39. J.C. Shah, Y. Sadhale, and D.M. Chilukuri Cubic phase gels as drug delivery systems Adv. Drug Deliv. Rev. 47 2001 229 250 (Pubitemid 32324116)
40. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann, and K. Maeder Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy J. Control. Rel. 95 2004 217 227 (Pubitemid 38230037)
41. G. Worle, M. Drechsler, M.H.J. Koch, B. Siekmann, K. Westesen, and H. Bunjes Influence of composition and preparation parameters on the properties of aqueous Monoolein dispersions Int. J. Pharm. 329 2007 150 157 (Pubitemid 44940847)
42. V. Luzzati, H. Delacroix, A. Gulik, T. Gulik-Krzywicki, P. Mariani, and R. Vargas The cubic phases of lipids Curr. Top. Membr. 44 1997 3 24
43. M. Pisani, S. Bernstorff, C. Ferrero, and P. Mariani Pressure induced cubic-to-cubic phase transition in Monoolein hydrated system J. Phys. Chem. B 105 2001 3109 3119
44. A. Yaghmur, L. de Campo, S. Salentinig, L. Sagalowicz, M.E. Leser, and O. Glatter Oil-loaded monolinolein-based particles with confined inverse discontinuous cubic structure (Fd3m) Langmuir 22 2006 517 521 (Pubitemid 43164784)
45. A. Di Stefano, P. Sozio, A. Iannitelli, and L.S. Cerasa New drug delivery strategies for improved Parkinson's disease therapy Expert Opin. Drug Del. 6 2009 389 404
46. G. Modi, V. Pillay, Y.E. Choonara, V.M. Ndesendo, L.C. du Toit, and D. Naidoo Nanotechnological applications for the treatment of neurodegenerative disorders Prog. Neurobiol. 88 2009 272 285
47. J.A. Obeso, F. Grandas, M.T. Herrero, and R. Horowski The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease Eur. J. Neurosci. 6 1994 889 897 (Pubitemid 24185313)
48. Y. Sadzuka, R. Hirama, and T. Sonobe Effects of intraperitoneal administration of liposomes and methods of preparing liposomes for local therapy Toxicol. Lett. 126 2002 83 90 (Pubitemid 34075265)
49. J.K. Vasir, M.K. Reddy, and V.D. Labhasetwar Nanosystems in drug targeting: opportunities and challenges Curr. Nanosci. 1 2005 47 64
50. T.M. Allen, C.B. Hansen, and L.S.S. Guo Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection Biochim. Biophys. Acta 1150 1993 9 169
51. L.H. Reddy, R.K. Sharma, K. Chuttani, A.K. Mishra, and R.S.R. Murthy Influence of administration route on tumour uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumour bearing mice J. Control. Rel. 105 2005 185 198 (Pubitemid 40941985)
52. L.H. Reddy, and R.S.R. Murthy Pharmacokinetics and biodistribution studies of doxorubicin loaded poly(butyl cyanoacrilate) nanoparticles synthesized by two different techniques Biomed. Papers 148 2 2004 161 166